5Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin - binding protein- 2/vitaminD3 up- regulated protein 1 as a negative regulator of thioredoxin function and expression [ J ]. J Biol Chem, 1999,274 (31) :21645 - 21650.
6Minn AH. Hafele X. Shalev A. Thioredoxin - interacting protein is stimulated by glucose through a carbohydrate response element and in- duces - cell apoptosis [ J ]. Endocrinology,2005,146:2379 - 2405.
7Verheul HM,Pinedo HM.Vascular endothelial growth factor and its inhibitors[J].Drugs Today,2003,39 Suppl C:81-93.
8Sung JK,Koh JH,Lee MY,et al.Aldose reductase inhibitor ameliorates renal vascular endothe-lial growth factor expression in streptozotocin-induced diabetic rats[J].Yonsei Med J,2010,51:385-391.
9Quattrini C,Jeziorska M,Boulton AJ,et al.Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy[J].Diabetes Care,2008,31:140-145.
10Urso C,Caimi G.Oxidative stress and endothelial dysfunction[J].Minerva Med,2011,102(1):59-77.
7Pan CY, Lu JM,Tian H,etal. Study of prevenlence of diabetes melli-tus in adults in the Shougang Corporation in Beijing[ J]. Diabet Med,1996,13:663 -668.
